Faculty & Scientific Staff
Background
Dr. DeBerg completed her PhD in physics at the University of Illinois at Urbana Champaign, using single-molecule fluorescence microscopy approaches to study motor proteins. Following her PhD, Hannah moved to Seattle and completed a postdoc at the University of Washington in the chemistry and biophysics departments. She joined BRI in 2015 as a bioinformatician in Peter Linsley’s laboratory where she became fascinated by the immune system.
Area of Research
Dr. DeBerg currently serves as the Bioinformatics Group Manager where she continues to enjoy working at the intersection of immunology, big data and advanced analysis.
Featured Publications
Dec 2023
An IL-2 mutein increases IL-10 and CTLA-4-dependent suppression of dendritic cells by regulatory T cells.
bioRxiv
Jamison BL, Lawrance M, Wang CJ, DeBerg HA, Sansom DM, Gavin MA, Walker LSK, Campbell DJ
Dec 2023
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.
Allergy
Voskamp AL, Khosa S, Phan T, DeBerg HA, Bingham J, Hew M, Smith W, Abramovitch J, Rolland JM, Moyle M, Nadeau KC, Lack G, Larché M, Wambre E, O'Hehir RE, Hickey P, Prickett SR
Nov 2023
Safety and immunopharmacology of ASP0892 in adults or adolescents with peanut allergy: two randomized trials.
Allergy
Ferslew BC, Smulders R, Zhu T, Blauwet MB, Kusawake T, Spence A, Aldridge K, DeBerg HA, Khosa S, Wambre E, Chichili GR
Sep 2023
Proinflammatory islet antigen reactive CD4 T cells are linked with response to alefacept in type 1 diabetes.
JCI Insight
Balmas E, Chen J, Hu AK, DeBerg HA, Rosasco MG, Gersuk VH, Serti E, Speake C, Greenbaum CJ, Nepom GT, Linsley PS, Cerosaletti K
May 2022
Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells.
Nat Genet
Mouri K, Guo MH, de Boer CG, Lissner MM, Harten IA, Newby GA, DeBerg HA, Platt WF, Gentili M, Liu DR, Campbell DJ, Hacohen N, Tewhey R, Ray JP
